Cargando…

Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling

The lack of robust Parkinson's disease (PD) phenotype in parkin knockout rodents and the identification of defective dopaminergic (DA) neurotransmission in midbrain DA neurons derived from induced pluripotent stem cells (iPSC) of PD patients with parkin mutations demonstrate the utility of pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zhixing, Pu, Jiali, Jiang, Houbo, Zhong, Ping, Qiu, Jingxin, Li, Feng, Wang, Xiaomin, Zhang, Baorong, Yan, Zhen, Feng, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2015
Materias:	Original Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620536/ https://www.ncbi.nlm.nih.gov/pubmed/26218671 http://dx.doi.org/10.1089/scd.2015.0079

Ejemplares similares

TET1 Deficiency Impairs Morphogen-free Differentiation of Human Embryonic Stem Cells to Neuroectoderm
por: Li, Hanqin, et al.
Publicado: (2020)

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
por: Li, Hong, et al.
Publicado: (2018)

Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos
por: Hu, Zhixing, et al.
Publicado: (2020)

Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson’s Disease
por: Si, Xiaoli, et al.
Publicado: (2017)

Decreased risk of Parkinson’s disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis
por: Zhu, Yueli, et al.
Publicado: (2019)

Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson’s Disease
por: Zheng, Ran, et al.
Publicado: (2022)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

ALFF and ReHo Mapping Reveals Different Functional Patterns in Early- and Late-Onset Parkinson’s Disease
por: Yue, Yumei, et al.
Publicado: (2020)

Brain Atrophy and Reorganization of Structural Network in Parkinson's Disease With Hemiparkinsonism
por: Xu, Xiaojun, et al.
Publicado: (2018)

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
por: Kang, Ji-feng, et al.
Publicado: (2016)

Straight sinus dural arteriovenous fistula presenting with reversible parkinsonism: A case report and literature review
por: Pu, Jiali, et al.
Publicado: (2017)

Efficient Culturing and Genetic Manipulation of Human Pluripotent Stem Cells
por: Schinzel, Robert T., et al.
Publicado: (2011)

Aquaporin-4 Polymorphisms Are Associated With Cognitive Performance in Parkinson’s Disease
por: Fang, Yi, et al.
Publicado: (2022)

Clinically relevant connectivity features define three subtypes of Parkinson's disease patients
por: Guo, Tao, et al.
Publicado: (2020)

Recent Advances: Decoding Alzheimer’s Disease With Stem Cells
por: Fang, Yi, et al.
Publicado: (2018)

Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson’s disease
por: Shen, Ting, et al.
Publicado: (2022)

The effects of AQP4 rs162009 on resting‐state brain activity in Parkinson's disease
por: Jiang, Mengze, et al.
Publicado: (2023)

Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks
por: Wen, Jiaqi, et al.
Publicado: (2022)

Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson’s disease
por: Shen, Ting, et al.
Publicado: (2018)

Altered Cortical Cholinergic Network in Parkinson’s Disease at Different Stage: A Resting-State fMRI Study
por: Sheng, Wenshuang, et al.
Publicado: (2021)

Base Editing Mediated Generation of Point Mutations Into Human Pluripotent Stem Cells for Modeling Disease
por: Qi, Tao, et al.
Publicado: (2020)

Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease
por: Guan, Xiaojun, et al.
Publicado: (2019)

Normalization effect of levodopa on hierarchical brain function in Parkinson’s disease
por: Guo, Tao, et al.
Publicado: (2022)

Early-Onset Parkinson's Disease Caused by PLA2G6 Compound Heterozygous Mutation, a Case Report and Literature Review
por: Shen, Ting, et al.
Publicado: (2019)

Melatonin Attenuates Neuroinflammation by Down-Regulating NLRP3 Inflammasome via a SIRT1-Dependent Pathway in MPTP-Induced Models of Parkinson’s Disease
por: Zheng, Ran, et al.
Publicado: (2021)

Epigenetic Manipulation Facilitates the Generation of Skeletal Muscle Cells from Pluripotent Stem Cells
por: Akiyama, Tomohiko, et al.
Publicado: (2017)

Pluripotent stem cells for Parkinson's disease: progress and challenges
por: Zeng, Xianmin, et al.
Publicado: (2013)

Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application
por: Xu, Lingjia, et al.
Publicado: (2016)

Asymmetrical nigral iron accumulation in Parkinson’s disease with motor asymmetry: an explorative, longitudinal and test-retest study
por: Guan, Xiaojun, et al.
Publicado: (2020)

Efficient treatment of Parkinson’s disease using ultrasonography-guided rhFGF20 proteoliposomes
por: Niu, Jianlou, et al.
Publicado: (2018)

Time Perception of an Artwork’s Manipulation Is Distorted by Patients With Parkinson’s Disease
por: Motta, Márcia Regina, et al.
Publicado: (2019)

Longitudinal Macro/Microstructural Alterations of Different Callosal Subsections in Parkinson’s Disease Using Connectivity-Based Parcellation
por: Wu, Jingjing, et al.
Publicado: (2020)

Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
por: Byers, Blake, et al.
Publicado: (2012)

Using induced pluripotent stem cells for modeling Parkinson’s disease
por: Ke, Minjing, et al.
Publicado: (2019)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
por: Yefroyev, David A, et al.
Publicado: (2022)

Cell therapy for Parkinson’s disease with induced pluripotent stem cells
por: Morizane, Asuka
Publicado: (2023)

Manipulating the Mediator complex to induce naïve pluripotency
por: Lynch, Cian J., et al.
Publicado: (2020)

Cholinergic relevant functional reactivity is associated with dopamine responsiveness of tremor in Parkinson’s disease
por: Wu, Jingjing, et al.
Publicado: (2022)

Gray and white matter alterations in different predominant side and type of motor symptom in Parkinson's disease
por: Chen, Jingwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1dqerimvd904o91orpapjvvk01